GET THE APP

Journal of Next Generation Sequencing & Applications

Journal of Next Generation Sequencing & Applications
Open Access

ISSN: 2469-9853

+44 1250400002

Journal of Next Generation Sequencing & Applications : Citations & Metrics Report

Articles published in Journal of Next Generation Sequencing & Applications have been cited by esteemed scholars and scientists all around the world. Journal of Next Generation Sequencing & Applications has got h-index 3, which means every article in Journal of Next Generation Sequencing & Applications has got 3 average citations.

Following are the list of articles that have cited the articles published in Journal of Next Generation Sequencing & Applications.

  2020 2019 2018 2017 2016

Year wise published articles

27 0 1 12 29

Year wise citations received

4 4 5 5 5
Journal total citations count 30
Journal impact factor 4.00
Journal 5 years impact factor 0.30
Journal cite score 0.43
Journal h-index 3
Journal h-index since 2016 3
Important citations

Venkatesan S, Birkbak NJ, Swanton C (2017) Constraints in cancer evolution. Biochemical Society Transactions. 45:1-3.

Zechner D, Bürtin F, Albert AC, Zhang X, Kumstel S, et al.(2016) Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin. Oncotarget 756395.

Kimani SG, Kumar S, Bansal N, Singh K, Kholodovych V, et al (2017 ) Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity. Scientific reports 7: 43908.

Luz FA, Brígido PC, Moraes AS, Silva MJ (2017) Aberrant splicing in cancer: Mediators of malignant progression through an imperfect splice program shift. Oncology 92: 3-13.

Ciavatta ML, Lefranc F, Carbone M, Mollo E, Gavagnin M, Betancourt T, et al (2017 ) Marine Mollusk‐Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. Medicinal research reviews 37: 702-801.

Efferth T, Saeed ME, Mirghani E, Alim A, Yassin Z,et al (2017 ) Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget 8: 50284.

Greene SB, Dago AE, Leitz LJ, Wang Y, Lee J,et al (2016) Chromosomal instability estimation based on next generation sequencing and single cell genome wide copy number variation analysis. PloS one 11: 0165089.

FriedmanR (2016 ) Drug resistance in cancer: molecular evolution and compensatory proliferation. Oncotarget 7: 11746.

Li YH, Yu CY, Li XX, Zhang P, Tang J, et al (2017 ) Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic acids research 46: 1121-1127.

Hu Z, Sun R, Curtis C (2017 ) A population genetics perspective on the determinants of intra-tumor heterogeneity. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1867: 109-126.

Marum JE, Branford S (2016 ) Current developments in molecular monitoring in chronic myeloid leukemia. Therapeutic advances in hematology 7: 237-251.

Terenzi A, Pirker C, Keppler BK, Berger W (2016) Anticancer metal drugs and immunogenic cell death. Journal of inorganic biochemistry 165: 71-79.

Penault-Llorca F, Radosevic-Robin N (2016 ) Biomarkers of residual disease after neoadjuvant therapy for breast cancer. Nature Reviews Clinical Oncology 13: 487.

Passaro A, Guerini-Rocco E, Pochesci A, Vacirca D, Spitaleri G, et al. (2017 ) Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment. Pharmacological research 117: 406-415.

Ganai RA, Johansson E (2016 ) DNA replication—a matter of fidelity. Molecular cell. 62: 745-755.

Kortüm KM, Mai EK, Hanafiah NH, Shi CX, Zhu YX, et al.(2016 ) Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes. Blood.

Lee G, Lee HY, Park H, Schiebler ML, van Beek EJ, et al (2017) Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: state of the art. European journal of radiology 86: 297-307.

Denisenko TV, Sorokina IV, Gogvadze V, Zhivotovsky B (2016 ) Mitotic catastrophe and cancer drug resistance: A link that must to be broken. Drug resistance updates 24: 1-2.

Lopez JS, Banerji U (2017 ) Combine and conquer: challenges for targeted therapy combinations in early phase trials. Nature reviews Clinical oncology 14: 57.

Kalia A (2018 ) Nanotechnology in Bioengineering: Transmogrifying Plant Biotechnology. In Omics Technologies and Bio-Engineering pp.211-229.

Relevant Topics

Top